Evidence map›Paper›PMID 33271927›Full record

ReviewInternational journal of molecular sciences2020

Organic Cation Transporters in the Lung-Current and Emerging (Patho)Physiological and Pharmacological Concepts.

Mohammed Ali Selo, Johannes A Sake, Carsten Ehrhardt, Johanna J Salomon

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Transporter-Mediated Drug Delivery.Molecules (Basel, Switzerland) · 2023
    Review
  9. Interaction of Masitinib with Organic Cation Transporters.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Mohammed Ali SeloSchool of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-6814-4575
Johannes A SakeSchool of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-8428-7373
Carsten EhrhardtSchool of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute (TBSI), Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0003-0730-1829
Johanna J SalomonTranslational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Department of Translational Pulmonology, University of Heidelberg, 69120 Heidelberg, Germany.
Trinity College Dublin · IEHeidelberg University · DE

Funding

Enterprise Ireland IP/2019/0797
6 · The paper itself

Abstract

Organic cation transporters (OCT) 1, 2 and 3 and novel organic cation transporters (OCTN) 1 and 2 of the solute carrier 22 (SLC22) family are involved in the cellular transport of endogenous compounds such as neurotransmitters, l-carnitine and ergothioneine. OCT/Ns have also been implicated in the transport of xenobiotics across various biological barriers, for example biguanides and histamine receptor antagonists. In addition, several drugs used in the treatment of respiratory disorders are cations at physiological pH and potential substrates of OCT/Ns. OCT/Ns may also be associated with the development of chronic lung diseases such as allergic asthma and chronic obstructive pulmonary disease (COPD) and, thus, are possible new drug targets. As part of the Special Issue "Physiology, Biochemistry and Pharmacology of Transporters for Organic Cations", this review provides an overview of recent findings on the (patho)physiological and pharmacological functions of organic cation transporters in the lung.

Indexed as

AnimalsBiological TransportDisease SusceptibilityGene ExpressionHomeostasisHumansLungOrganic Cation Transport ProteinsProtein IsoformsRespiratory MucosaOrganic Cation Transport ProteinsProtein Isoformsanticholinergicschronic lung diseasesdrug uptakelung epitheliumpulmonary drug deliverySLC22A1–5β2-agonists

Identifiers

PMID33271927
PMCPMC7730617
OpenAlexW3110054460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.